Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Support through Mobile Messaging and digital health Technology for Diabetes

Summit d full rgb_small for web.jpg
Shutterstock_497558443.jpg

Type 2 diabetes affects 2.9 million people in the UK. Tablet medications which are taken to reduce risks of complications are effective if taken as intended but concerns about medicines and difficulties with taking them regularly are common.  Between a third and half of the medicines used to treat this condition are not taken as prescribed.

There is some evidence that receiving brief text messages can help people to take their medications as prescribed and to manage their health condition. However, more research is needed to develop such messages, embed them in health care delivery systems, and test whether they work when used at a wide scale.

Collaborators:

University of Manchester

Recruitment starts:

November 2018

Contact us:

Oxford:

Email: summit-d@phc.ox.ac.uk
Telephone: 0808 164 2521

Manchester:

Email: summit-d@manchester.ac.uk
Telephone: 01612 757 610

This six-year study is funded by the National Institute for Health Research. Ethics Ref: 18/WS/0173

Summit d magnifying glass.png

Step 1:

Check the map below to make sure your GP surgery is taking part in the study. If they're not taking part, let us know and we can contact them for you. Can't see the map? Click here.

Summit d leaflet.png

Step 2:

If you are in the north of England, read the information sheet:

Download - full

If you are in the south of England, read the information sheet:

Download - full
Summit d phone.png

Step 3:

In you are in the north of England, to join the study:
Text: 'Register' + your full name to 07422129245

If you are in the south of England, to join the study:
Text: 'Register' + your full name to 07422128690

We are recruiting!

  • Patients over 35 years old who are taking tablet medication for their type 2 diabetes who have had a change in their tablet medication within the past three months will be invited to take part in SuMMiT-D.
  • Patients will be randomly assigned to either the tailored messages (intervention) or general messages (control) groups.
  • The tailored messages group will receive three text messages per week.
  • The general message group will receive one message per month.
  • Interested in joining the study? Check out the three easy steps for guidance.

Updates:

More updates

What other work are we doing?

Read more

Meet the team: